Cardiovascular disease
Conditions
Interventions
Cardiomyopathy (Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy):None
Ion Channel Disease:None
High-risk Group For Sudden Cardiac Death:None
Sponsors
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Patients aged >= 18 years who are able to provide informed consent and voluntarily participate in the study; (2) Patients diagnosed with one of the following five types of cardiovascular diseases: coronary heart disease, cardiomyopathy (hypertrophic cardiomyopathy, dilated cardiomyopathy), valvular heart disease, ion channel disease, or atrial fibrillation; (3) Patients at high risk of sudden cardiac death (SCD) must meet the Class I and IIa recommended indications for ICD implantation as outlined in the "Chinese Expert Consensus on the Clinical Application of Implantable Cardioverter-Defibrillators (2021)."
Exclusion criteria
Exclusion criteria: (1) Patients who are unable to sign an informed consent form; (2) Patients with poor compliance who are not expected to complete long-term follow-up; (3) Patients with other serious diseases or an expected lifespan of less than 3 years; (4) Patients who may affect the accuracy of research data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major cardiovascular events, MACE;Sudden cardiac death; | — |
Countries
China
Contacts
Public ContactYangxin Chen
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Outcome results
None listed